ABSTRACT
Background@#Despite the numerous treatment options for cutaneous warts, choosing the appropriate method for optimum results can be challenging. Treatment strategies should be individualized according to the patient and lesion characteristics. However, there is a paucity of research on the clinical factors predicting treatment response. @*Objective@#To investigate the efficacy of diphenylcyclopropenone immunotherapy for warts, based on anatomical location @*Methods@#This retrospective study included 262 wart lesions from 99 patients treated with diphenylcyclopropenone immunotherapy for warts between 2007 and 2018. The lesions were divided into three groups−periungual wart, palmoplantar wart, or hair-bearing skin wart−according to anatomical location. Periungual warts were divided into hyponychium, proximal nail fold, and lateral nail fold-type subgroups. Treatment success rates were compared between the groups. @*Results@#The treatment success rate of periungual warts (75.3%) was significantly higher than those of palmoplantar (60.4%) and hair-bearing skin (60.3%) warts. No significant differences were observed between the treatment success rates of the periungual wart subgroups. @*Conclusion@#Diphenylcyclopropenone immunotherapy is an effective treatment modality for periungual warts.
ABSTRACT
No abstract available.
Subject(s)
Diagnosis , Emergencies , Emergency Service, Hospital , KoreaABSTRACT
Orofacial granulomatosis is a rare granulomatous inflammatory disease, characterized by recurrent orofacial swelling. Infectious, genetic, and immunologic etiologies are suggested, but not fully understood. Herein, we report a case of synchronous orofacial granulomatosis with brain cavernous hemangioma in a 44-year-old female patient, which may be considered paraneoplastic syndrome.
Subject(s)
Adult , Female , Humans , Brain , Granulomatosis, Orofacial , Hemangioma, Cavernous , Hemangioma, Cavernous, Central Nervous System , Paraneoplastic SyndromesABSTRACT
No abstract available.